Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark.
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Obes Facts. 2022;15(2):150-159. doi: 10.1159/000520200. Epub 2021 Dec 13.
Body mass index (BMI) is often elevated at type 2 diabetes (T2D) diagnosis. Using latent class trajectory modelling (LCTM) of BMI, we examined whether weight loss after diagnosis influenced cancer incidence and all-cause mortality.
From 1995 to 2010, we identified 7,708 patients with T2D from the Salford Integrated Record database (UK) and linked to the cancer registry for information on obesity-related cancer (ORC), non-ORC; and all-cause mortality. Repeated BMIs were used to construct sex-specific latent class trajectories. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox regression models.
Four sex-specific BMI classes were identified; stable-overweight, stable-obese, obese-slightly-decreasing, and obese-steeply-decreasing; comprising 41%, 45%, 13%, and 1% of women, and 45%, 37%, 17%, and 1% of men, respectively. In women, the stable-obese class had similar ORC risks as the obese-slightly-decreasing class, whereas the stable-overweight class had lower risks. In men, the obese-slightly-decreasing class had higher risks of ORC (HR = 1.86, 95% CI: 1.05-3.32) than the stable-obese class, while the stable-overweight class had similar risks No associations were observed for non-ORC. Compared to the stable-obese class, women (HR = 1.60, 95% CI: 0.99-2.58) and men (HR = 2.37, 95% CI: 1.66-3.39) in the obese-slightly-decreasing class had elevated mortality. No associations were observed for the stable-overweight classes.
Patients who lost weight after T2D diagnosis had higher risks for ORC (in men) and higher all-cause mortality (both genders) than patients with stable obesity.
在 2 型糖尿病(T2D)诊断时,体重指数(BMI)通常升高。我们使用 BMI 的潜在类别轨迹建模(LCTM)来检查诊断后体重减轻是否会影响癌症发病率和全因死亡率。
我们从 1995 年至 2010 年从英国索尔福德综合记录数据库中确定了 7708 名 T2D 患者,并与癌症登记处链接,以获取肥胖相关癌症(ORC)、非 ORC 和全因死亡率的信息。重复的 BMI 用于构建性别特异性潜在类别轨迹。使用 Cox 回归模型估计风险比(HR)和 95%置信区间(CI)。
确定了四个性别特异性 BMI 类别;稳定超重、稳定肥胖、肥胖略减和肥胖急剧减少;分别占女性的 41%、45%、13%和 1%,男性的 45%、37%、17%和 1%。在女性中,稳定肥胖组与肥胖略减组的 ORC 风险相似,而稳定超重组的风险较低。在男性中,肥胖略减组的 ORC 风险较高(HR=1.86,95%CI:1.05-3.32)比稳定肥胖组,而稳定超重组的风险相似。未观察到非 ORC 的关联。与稳定肥胖组相比,肥胖略减组的女性(HR=1.60,95%CI:0.99-2.58)和男性(HR=2.37,95%CI:1.66-3.39)的死亡率较高。未观察到稳定超重组的关联。
T2D 诊断后体重减轻的患者比稳定肥胖的患者发生 ORC(男性)和全因死亡率(两性)的风险更高。